Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2017	Jan. 31, 2016
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853
Shareholders' deficiency, beginning balance	$ (421,404)	$ (341,488)
Net loss	$ (88,235)	$ (79,916)
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ (509,639)	$ (421,404)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, beginning balance	$ 1,233	$ 1,233
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	81,323	81,323
Shareholders' deficiency, ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	(503,960)	(424,044)
Net loss	(88,235)	(79,916)
Shareholders' deficiency, ending balance	$ (592,195)	$ (503,960)